C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Price:
1.81
HKD
-0.55%
Market Closed
Market Cap:
HK$9.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
HK |
|
A
|
Aplab Ltd
BSE:517096
|
IN |
|
Maharah for Human Resources Company SJSC
SAU:1831
|
SA |
|
TietoEVRY Corp
F:TTEB
|
FI |
|
U
|
UCAL Ltd
NSE:UCAL
|
IN |
|
Vision Marine Technologies Inc
NASDAQ:VMAR
|
CA |
|
Vontron Technology Co Ltd
SZSE:000920
|
CN |
|
P
|
PTG Energy PCL
SET:PTG
|
TH |
|
M
|
MDS Tech Inc
KOSDAQ:086960
|
KR |
|
R
|
Rusta AB (publ)
STO:RUSTA
|
SE |
|
California Style Palms Inc
OTC:CFPI
|
US |
|
Anhui Xinbo Aluminum Co Ltd
SZSE:003038
|
CN |
|
Diamcor Mining Inc
XTSX:DMI
|
CA |
Multiples-Based Value
The Multiples-Based Value for China Traditional Chinese Medicine Holdings Co Ltd (570) under the Base Case is hidden HKD. Compared with the current market price of 1.81 HKD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China Traditional Chinese Medicine Holdings Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
China Traditional Chinese Medicine Holdings Co Ltd Competitors
China Traditional Chinese Medicine Holdings Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
9.1B HKD | 0.5 | -23.5 | 7.4 | 7.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.4 | 13.3 | 17 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
